Casandra
Casandra Test Code PG61104Version 1 (DRAFT)
Performing Lab
Lab Prevention GeneticsLab Test ID 10359
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel
Clinical Use
Order TestUse
This test is intended for individuals who have a clinical or suspected diagnosis of amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD), as well as those with a family history of ALS or FTD.
Special Instructions
Not provided.
Limitations
This test has not been cleared or approved by the US Food and Drug Administration. It is validated under CAP and CLIA regulations, but regulatory validation does not imply clinical utility or effectiveness.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Mutation (17 genes)
ALS2ANGCHCHD10CHMP2BC9orf72DCTN1FUSGRNHNRNPA1HNRNPA2B1MAPTOPTNPFN1SQSTM1TARDBPTBK1VCP
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided